Angiosome: Is It Feasible in Critical Limb Ischemia?

Courtesy of Dr. Carlos Fava.

 

Angiosome Critical Limb Ischemia

Critical limb ischemia (CLI) accompanied by tissue loss entails high risk of amputation. At present, there is substantial evidence in favor of revascularization by PCI according to the angiosome concept, but the feasibility of this treatment remains unclear.

 

161 compromised limbs were analyzed in 160 patients with foot ulcers undergoing below-the-knee (BTK) interventions. Mean age was 75, and 67% of patients were diabetic. They were all 5 or 6 Rutherford stage.

 

Lesions were associated to:

  • Only one angiosome in 39 patients (24%)
  • 2 angiosomes in 75 patients (46.6%)
  • 3 angiosomes in 42 patients (26.1%)
  • 4 angiosomes in 4 patients (2.5%)
  • 5 angiosomes in 1 patient (0.6%)

 

Direct flow to the affected angiosome was achieved in 98 patients (60.9%). Researchers analyzed the number of angiosomes associated to ulcers and revascularization success rate. If ulcers were associated to:

  • 1 angiosome, revascularization was successful in 27 patients (69.2%)
  • 2 angiosomes, it was successful in 65 patients (86.7%)
  • 3 angiosomes, it was successful in 36 patients (85.7%)
  • 4 angiosomes, it was successful in 1 patient (25%)
  • 5 angiosomes, there was no chance of revascularization

 

Conclusion

In critical limb ischemia, tissue lesions mostly affect several angiosomes. In the literature published so far, there is evidence on angiosome targeted revascularization when more than one angiosome is compromised and we need consensus to achieve an exact definition.

 

Editorial Comment

Cases of CLI are dramatically increasing, and they are accompanied by a significant rate of amputation.

Multiple publications have shown the benefits of the angiosome concept and this analyzis shows it is feasible in little more than half of patients.

 

We should incorporate the concept of angiosome targeted revascularization in CLI knowing that it involves longer procedural time, the need of new strategies and new materials to become more effective with this group of patients.

 

Courtesy of Dr. Carlos Fava. Favaloro Foundation, Buenos Aires, Argentina.

 

Original Title: The Feasibility of Angisome-Targeted Endovascular Treatment in Patients with Critical Limb Ischemia and Foot Ulcer.

Reference: Kristýna Spillerová et al. Ann Vasc Surg 2016;30:20-70-276.

 

We value your opinion. You are more than welcome to leave your comments, thoughts, questions or suggestions here below.

More articles by this author

A New Asymptomatic Carotid Stenosis Paradigm? CREST-2 Trial Unified Results

Severe asymptomatic carotid stenosis continues to be controversial seeing the optimization of intensive medical therapy (IMT) and the availability lower periprocedural risk revascularization techniques....

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Abdominal aortic aneurysm (AAA) is a deadly vascular disease with no effective drug treatment, and risk of rupture reaching up to 80%. Even though...

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...